UBP-302
Sign in to saveAlso known as UBP302, UBP 302
UBP-302 is a highly selective kainate receptor antagonist used in the study of many neurological processes. It is active at micromolar concentration within an in vitro preparation and specifically targets the GluK1 (iGluR5) subunit of the receptor. This compound was developed at the University of Bristol.
Wikidata facts
- Mass
- 333.096
Show 3 more facts
- canonical SMILES
- C1=CC=C(C(=C1)CN2C(=O)C=CN(C2=O)CC(C(=O)O)N)C(=O)O
- chemical formula
- C₁₅H₁₅N₃O₆
- isomeric SMILES
- C1=CC=C(C(=C1)CN2C(=O)C=CN(C2=O)C[C@@H](C(=O)O)N)C(=O)O
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 443145597 | ImageFile = UBP-302.png | ImageClass = skin-invert-image | ImageSize = 240px | SystematicName=2-({3-[(2S)-2-Amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid | OtherNames= |Section1= |Section2= |Section3= }}
UBP-302 is a highly selective kainate receptor antagonist used in the study of many neurological processes. It is active at micromolar concentration within an in vitro preparation and specifically targets the GluK1 (iGluR5) subunit of the receptor. This compound was developed at the University of Bristol.
Excerpted from Wikipedia’s “UBP-302” article, available under the CC BY-SA 4.0 licence.